Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice

Overview of attention for article published in OncoTargets and therapy, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 2 public wall posts from 1 users.

The combination treatment with vemurafenib/cobimetinib results in an important impact on long-term survival, leading to a…

The combination treatment with vemurafenib/cobimetinib results in an important impact on long-term survival, leading to a…